05:14:03 EDT Tue 21 May 2019
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save
Cannabis Summary
Symbol C : *MKTPOT
Recent Sedar Documents

Cannabis Summary for May 15, 2019

2019-05-15 20:55 ET - Market Summary

This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

by Stockwatch Business Reporter

The Canadian Securities Exchange Composite Index lost 13.67 points to 834.52 Wednesday. Aurora Cannabis Inc. (ACB) rose 35 cents to $11.67 on 28.69 million shares after the company reported revenue of $75.23-million in its fiscal third quarter of 2019, up from $62-million in the previous quarter. The biggest increase in its revenue came from the Canadian recreational market. Though the company is still far from profitable, it managed to decrease the cash cost of producing a gram by 26 per cent to $1.42 per gram. Aurora doubled its production capacity to 15,590 kilograms compared with the fiscal second quarter.

The company already completed a $345-million (U.S.) convertible note offering in January, 2019. Near the bottom of its long Q3 results news release, Aurora Cannabis revealed that it has filed a prospectus for a $400-million (U.S.) offering on the New York Stock Exchange. With all $400-million (U.S.) worth of shares issued, the financing would dilute current shareholders by about 5 per cent. The shares will be issued from time to time at Aurora's discretion over a period of up to 25 months. The company says it will use the proceeds for future acquisitions, debt repayments, capital expenditures and working capital; in other words, just about anything.

The remainder is available to Stockwatch subscribers.
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

© 2019 Canjex Publishing Ltd. All rights reserved.


Reader Comments - Comments are open to paying subscribers of Stockwatch and unmoderated, although libelous remarks, obscene language and impersonations may be deleted. Opinions expressed do not necessarily reflect the views of Stockwatch.
For information regarding Canadian libel law, please view the University of Ottawa's FAQ regarding Defamation and SLAPPs.